Drug bill with exemptions for LTC pharmacies heads to Obama
A bill that would exempt long-term care pharmacies from a controversial “lock-in” provision received final passage from the Senate on Wednesday and now heads to the president’s desk.
The Comprehensive Addiction and Recovery Act includes language that would require Medicare Part D beneficiaries to use one pharmacy for all prescriptions, in an effort to lessen opioid abuse.
Long-term care pharmacy advocates condemned the “lock-in” clause, arguing that legislation already existed that protected beneficiaries in long-term care settings from drug abuse. Alan Rosenbloom, president of the Senior Care Pharmacy Coalition, praised the passage of the bill with the LTC exemption intact.
“The exemption is a vital provision that specifically recognizes the unique characteristics of the long-term care patient population and the distinctions between specialized long-term care pharmacies and more well-known retail pharmacies — particularly the additional requirements already imposed on LTC pharmacies under Medicare and Medicaid Requirements of Participation and Medicare Part D rules,” Rosenbloom said
Long-term care pharmacies’ tracking, auditing, packaging and dispensing of drugs helps them meet the “extraordinarily high” safety standards for Medicare Part D, Rosenbloom said. He also stressed the fact that pharmacists and licensed facility staff are the ones handling the prescription orders, not the beneficiaries themselves.
“CARA strikes the right balance between protecting our citizens and communities on the one hand, and protecting the ability of LTC pharmacies to meet and manage the medication needs of LTC residents on the other,” Rosenbloom said.
Obama is expected to sign the bill. CARA is estimated to receive $581 million in funding, which is set to be authorized by Senate Republicans in September after Congress’ summer recess.
Click here to see the original article on the McKnight’s website.
Recent Posts
-
SCPC Releases Statement in Support of Government Accountability Office (GAO) Report on the Inflation Reduction Act
SCPC has repeatedly warned about the impact of the Inflation Reduction Act’s (IRA) mandatory Medicare drug price negotiations on LTC pharmacies and the millions of vulnerable seniors they serve. We are glad the Government Accountability Office (GAO) is examining how these policies are affecting pharmacies, particularly LTC pharmacies, which already operate under a broken reimbursement model that often requires them to dispense many of the most commonly used medications at a loss.
-
SCPC Applauds President Trump’s Executive Order Calling on HHS and Congress to Improve the IRA, Rein In PBMs and Lower Drug Costs
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement applauding President Trump’s recent Executive Order aimed at improving the Inflation Reduction Act (IRA), lowering drug prices and addressing the harmful actions of PBMs. “For far too long, pharmacy benefit managers (PBMs) have taken […]
-
60 percent of LTC pharmacies warn of closure amid major drug pricing changes
Facing deep losses on high-demand medications, 85% of long-term care pharmacies say they will limit essential services and 60% will close locations without changes to Medicare drug pricing efforts. Those are among the “unintended consequences” revealed in a Senior Care Pharmacy Coalition survey released Wednesday. The trade association has been increasingly vocal about pricing changes set to go into effect in January.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.